JP2019537435A5 - - Google Patents

Download PDF

Info

Publication number
JP2019537435A5
JP2019537435A5 JP2019520956A JP2019520956A JP2019537435A5 JP 2019537435 A5 JP2019537435 A5 JP 2019537435A5 JP 2019520956 A JP2019520956 A JP 2019520956A JP 2019520956 A JP2019520956 A JP 2019520956A JP 2019537435 A5 JP2019537435 A5 JP 2019537435A5
Authority
JP
Japan
Prior art keywords
probe
spiked
sample
sampling
valid state
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2019520956A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019537435A (ja
Filing date
Publication date
Priority claimed from EP16194959.9A external-priority patent/EP3141611A3/en
Application filed filed Critical
Publication of JP2019537435A publication Critical patent/JP2019537435A/ja
Publication of JP2019537435A5 publication Critical patent/JP2019537435A5/ja
Ceased legal-status Critical Current

Links

JP2019520956A 2016-10-21 2017-10-19 連続式ウイルスクリアランスのバリデーション Ceased JP2019537435A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16194959.9 2016-10-21
EP16194959.9A EP3141611A3 (en) 2016-10-21 2016-10-21 Validation of continuous viral clearance
PCT/US2017/057298 WO2018075716A1 (en) 2016-10-21 2017-10-19 Validation of continuous viral clearance

Publications (2)

Publication Number Publication Date
JP2019537435A JP2019537435A (ja) 2019-12-26
JP2019537435A5 true JP2019537435A5 (cg-RX-API-DMAC7.html) 2020-06-18

Family

ID=57209212

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019520956A Ceased JP2019537435A (ja) 2016-10-21 2017-10-19 連続式ウイルスクリアランスのバリデーション

Country Status (16)

Country Link
US (1) US10894991B2 (cg-RX-API-DMAC7.html)
EP (2) EP3141611A3 (cg-RX-API-DMAC7.html)
JP (1) JP2019537435A (cg-RX-API-DMAC7.html)
KR (1) KR20190066017A (cg-RX-API-DMAC7.html)
CN (1) CN110100008A (cg-RX-API-DMAC7.html)
AR (1) AR109846A1 (cg-RX-API-DMAC7.html)
AU (1) AU2017345412A1 (cg-RX-API-DMAC7.html)
BR (1) BR112019007835A2 (cg-RX-API-DMAC7.html)
CA (1) CA3041253A1 (cg-RX-API-DMAC7.html)
IL (1) IL266095A (cg-RX-API-DMAC7.html)
MX (1) MX385466B (cg-RX-API-DMAC7.html)
RU (1) RU2755634C2 (cg-RX-API-DMAC7.html)
SG (1) SG10202104023QA (cg-RX-API-DMAC7.html)
TW (1) TW201827830A (cg-RX-API-DMAC7.html)
UY (1) UY37447A (cg-RX-API-DMAC7.html)
WO (1) WO2018075716A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019011900A1 (en) * 2017-07-10 2019-01-17 Baxalta Incorporated METHOD FOR LIQUID INCUBATION AND VIRUS INACTIVATION
EP4112735A4 (en) * 2020-02-28 2023-09-06 Asahi Kasei Medical Co., Ltd. Method for evaluating viral clearance performance
CN116261566A (zh) * 2020-09-21 2023-06-13 拜耳医药保健有限责任公司 病原体清除系统和方法
US12203914B2 (en) * 2020-11-12 2025-01-21 Sartorius Bioanalytical Instruments, Inc. Viral clearance evaluation for biological medical product preparation processes
EP4317460B1 (en) * 2021-03-26 2025-12-31 Asahi Kasei Life Science Corporation VIRAL CLEARANCE TEST PROCEDURE

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG184833A1 (en) * 2010-04-14 2012-11-29 Emd Millipore Corp Methods of producing high titer, high purity virus stocks and methods of use thereof
AU2014100888A4 (en) * 2014-08-07 2014-09-11 Novartis Ag Virus clearance and protein purification methods

Similar Documents

Publication Publication Date Title
JP2019537435A5 (cg-RX-API-DMAC7.html)
Gong et al. Matrix measure method for global exponential stability of complex-valued recurrent neural networks with time-varying delays
EP3562956A4 (en) METHODS, APPARATUS AND SYSTEMS FOR ANALYZING STRAINS OF MICRO-ORGANISMS IN COMPLEX HETEROGENEOUS COMMUNITIES, DETERMINING THEIR INTERACTIONS AND FUNCTIONAL RELATIONSHIPS, AND MANAGEMENT OF DIAGNOSTICS AND BIOLOGICAL STATES BASED ON THEM
IL258101A (en) Device and system for testing samples, especially blood, and methods for using them
Zhang et al. Bifurcation and optimal harvesting of a diffusive predator–prey system with delays and interval biological parameters
EP3327198A4 (en) RISS ANALYSIS DEVICE, RIP ANALYSIS METHOD AND RIP ANALYSIS PROGRAM
EP2291841A4 (en) METHOD, APPARATUS AND COMPUTER PROGRAM PROVIDING ENHANCED AUDIO PROCESSING
HK1217278A1 (zh) 用於呼吸氣體分析的採樣和存儲註冊裝置
WO2014160441A8 (en) Neuroactive steroids, compositions, and uses thereof
EP2259069A4 (en) APPARATUS FOR ANALYZING BLOOD COAGULATION, METHOD FOR ANALYZING BLOOD COAGULATION, AND COMPUTER PROGRAM
IT201600073964A1 (it) Nanointerruttore basato su nucleotidi e metodi per la rilevazione di anticorpi e altri analiti
EP4138484A4 (en) Resource determination method, resource indication method, and device
EP3921987C0 (en) APPARATUS, METHOD AND COMPUTER PROGRAM
EP3702942A4 (en) ANALYSIS SYSTEM, ANALYSIS METHOD AND PROGRAM
DK3868100T3 (da) Fremgangsmåde, computerprogramprodukt og enhed til dekodning af cbf-flag
MX2019004540A (es) Validacion de aclaramiento viral continuo.
EP3610275C0 (en) WAFER PROBE CARD, ANALYSIS APPARATUS COMPRISING SAID CARD AND METHOD FOR MANUFACTURING THE WAFER PROBE CARD
EP3909514A4 (en) DIAGNOSTIC ASSIST DEVICE, DIAGNOSTIC ASSIST METHOD AND PROGRAM
JP2015194403A5 (cg-RX-API-DMAC7.html)
Zhang The critical Neumann problem of Kirchhoff type
EP3540043A4 (en) ANALYSIS DEVICE, ANALYSIS METHOD, AND PROGRAM
EP3916655A4 (en) OPERATIONAL ANALYSIS DEVICE, OPERATIONAL ANALYSIS METHOD, OPERATIONAL ANALYSIS PROGRAM, AND OPERATIONAL ANALYSIS SYSTEM
EP4340410A4 (en) Server, request entity, and methods therefor
EP3457395A4 (en) MUSICAL STRUCTURE ANALYSIS DEVICE, STRUCTURE AND PROGRAM
Chen et al. Asymptotic expansions for the constants of Landau and Lebesgue